Citadel Advisors’s Vascular Solutions Inc VASC Stock Holding History

Citadel Advisors’s Portfolio VASC Stock Details VASC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-14,436	Closed	-$810K	–	8512
2016 Q4	$810K	Sell	14,436 -1,697	-11%	-$86.5K	﹤0.01%	4169
2016 Q3	$778K	Buy	+16,133	New	+$751K	﹤0.01%	4166
2016 Q2	–	Sell	-11,498	Closed	-$374K	–	7838
2016 Q1	$374K	Buy	11,498 +7,768	+208%	+$224K	﹤0.01%	4813
2015 Q4	$128K	Sell	3,730 -13,758	-79%	-$466K	﹤0.01%	6411
2015 Q3	$567K	Sell	17,488 -18,247	-51%	-$654K	﹤0.01%	4629
2015 Q2	$1.24M	Buy	35,735 +30,823	+628%	+$1.01M	﹤0.01%	3696
2015 Q1	$149K	Sell	4,912 -33,370	-87%	-$958K	﹤0.01%	6496
2014 Q4	$1.04M	Buy	38,282 +18,609	+95%	+$505K	﹤0.01%	3722
2014 Q3	$486K	Buy	19,673 +9,683	+97%	+$230K	﹤0.01%	4659
2014 Q2	$222K	Sell	9,990 -3,399	-25%	-$74.4K	﹤0.01%	5458
2014 Q1	$351K	Sell	13,389 -1,099	-8%	-$27.4K	﹤0.01%	4829
2013 Q4	$335K	Buy	+14,488	New	+$284K	﹤0.01%	4488

Other funds holding VASC

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Citadel Advisors's VASC Position: Q1 2017 in Review

Citadel Advisors sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 14,436 shares — an estimated $810K sold.

Citadel Advisors first reported a position in VASC in Q4 2013 and held it in 12 quarters. The position peaked at $1.24M in Q2 2015. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

Citadel Advisors reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
Citadel Advisors sold 14,436 Vascular Solutions Inc shares in Q1 2017, an estimated $810K.
Citadel Advisors first reported a position in Vascular Solutions Inc in Q4 2013 and held it in 12 quarters.
Citadel Advisors's Vascular Solutions Inc position peaked at $1.24M in Q2 2015.
1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.